Cytokinetics, Incorporated CYTK
NASDAQ · United States · Health Technology
$65.62-0.29 (-0.44%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.50 | -1.63 | +7.9% | $28.62M | +62.7% | -2.7%$78.85→$76.76 |
| Q1 2026 | 2026-05-05 | -1.67 | -1.67 | 0.0% | — | — | +13.3%$66.05→$74.84 |
| Q4 2025 | 2026-02-24 | -1.50 | -1.37 | -9.5% | — | — | -7.9%$68.26→$62.89 |
| Q3 2025 | 2025-11-05 | -1.54 | -1.59 | +3.1% | — | — | +1.1%$59.62→$60.30 |
| Q1 2025 | 2025-05-06 | -1.36 | -1.36 | 0.0% | — | — | — |
| Q4 2024 | 2025-02-27 | -1.26 | -1.17 | -7.7% | — | — | — |
| Q4 2023 | 2024-02-27 | -1.38 | -0.95 | -45.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.